Hot Pursuit     08-Jun-23
Zydus Life gets USFDA nod for hypertension drug
Zydus Lifesciences announced that it has received final approval from the United States Food and Drug Administration (USFDA) for Tadalafil tablets.
The said drug is equivalent to reference listed drug, Adcirca tablets. Tadalafil relaxes muscles of the blood vessels and increases blood flow to particular areas of the body. It is used to treat pulmonary arterial hypertension and improve exercise capacity in men and women.

The drug will be manufactured at the group's formulation manufacturing facility in Moraiya, Ahmedabad (India).

According to IQVIA MAT April 2023, Tadalafil tablets USP, 20 mg had annual sales of $61 million in the United States.

As of 31 March 2023, the group now has 369 approvals and has so far filed over 442 ANDAs since the commencement of the filing process in FY 2003-04.

Zydus Lifesciences is a discovery-driven, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies.

The company's consolidated net profit (from continuing operations) tumbled 27.55% to Rs 298.8 crore despite of 31.66% jump in total revenue from operations to Rs 5,010.6 crore in Q4 FY23 over Q4 FY22.

The scrip rose 0.18% to currently trade at Rs 515.95 on the BSE.

Previous News
  Zydus receives USFDA final approval for Cyclophosphamide Capsules
 ( Corporate News - 14-Dec-23   18:57 )
  Zydus receives USFDA approval for Theophylline ER Tablets
 ( Corporate News - 22-May-24   12:57 )
  Zydus Lifesciences to declare Quarterly Result
 ( Corporate News - 31-Jan-24   12:07 )
  Zydus completes Phase II clinical study of NLRP3 inhibitor ‘Usnoflast (ZYIL1)'
 ( Corporate News - 24-May-24   16:02 )
  Zydus receives USFDA approval for Norelgestromin and Ethinyl Estradiol Transdermal System
 ( Corporate News - 15-Sep-23   15:11 )
  Zydus Lifesciences Ltd gains for third straight session
 ( Hot Pursuit - 02-Jan-24   13:05 )
  Zydus Lifesciences Ltd soars 0.09%, rises for fifth straight session
 ( Hot Pursuit - 30-Jun-23   13:00 )
  Zydus Lifesciences Ltd soars 1.52%, rises for fifth straight session
 ( Hot Pursuit - 11-Mar-24   13:00 )
  Stocks in focus: Ajanta Pharma, Zydus Lifesciences, HAL, L&T, Deccan Gold Mines
 ( Market Commentary - Stock Alert 08-Mar-23   08:32 )
  Zydus Lifesciences appoints Punit Patel as Chief Executive Officer - Americas
 ( Corporate News - 16-Oct-23   10:24 )
  Zydus Lifesciences receives USFDA approval for Lubiprostone Capsules
 ( Corporate News - 24-Mar-23   14:54 )
Other Stories
  Eicher Motors CV sales rises 11% YoY in June’24
  01-Jul-24   15:39
  Atul Auto hits record high as sales double to 2,628 units in Jun’24
  01-Jul-24   15:29
  Ashok Leyland slides as total sales slips 2% YoY in June'24
  01-Jul-24   15:16
  Reliance Infrastructure Ltd leads losers in 'A' group
  01-Jul-24   15:00
  Oriental Carbon & Chemicals Ltd leads losers in 'B' group
  01-Jul-24   14:45
  Rane Holdings hits life high on plan to acquire 51% stake in JV
  01-Jul-24   14:45
  Maruti Suzuki rises as total sales jumps 12% YoY in Jun’24
  01-Jul-24   14:37
  Volumes jump at Emami Ltd counter
  01-Jul-24   14:30
  Karur Vysya Bank advances climb 16% YoY in Jun'24
  01-Jul-24   14:14
  SML Isuzu jumps as June sales surges 38% YoY
  01-Jul-24   14:13
Back Top